+Search query
-Structure paper
| Title | BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models. |
|---|---|
| Journal, issue, pages | Nat Cancer, Vol. 5, Page 1479-1493, Year 2024 |
| Publish date | Jun 15, 2023 (structure data deposition date) |
Authors | Rauh, U. / Wei, G. / Serrano-Wu, M. / Kosmidis, G. / Kaulfuss, S. / Siegel, F. / Thede, K. / McFarland, J. / Lemke, C.T. / Werbeck, N. ...Rauh, U. / Wei, G. / Serrano-Wu, M. / Kosmidis, G. / Kaulfuss, S. / Siegel, F. / Thede, K. / McFarland, J. / Lemke, C.T. / Werbeck, N. / Nowak-Reppel, K. / Pilari, S. / Menz, S. / Ocker, M. / Zhang, W. / Davis, K. / Poncet-Montange, G. / Roth, J. / Daniels, D. / Kaushik, V.K. / Hubbard, B. / Ziegelbauer, K. / Golub, T.R. |
External links | Nat Cancer / PubMed:39179926 |
| Methods | X-ray diffraction |
| Resolution | 1.56 Å |
| Structure data | ![]() PDB-8t6f: |
| Chemicals | ![]() ChemComp-MG: ![]()
ChemComp-YI7: ![]() ChemComp-DMS: ![]() ChemComp-PGE: ![]() ChemComp-HOH: |
| Source |
|
Keywords | APOPTOSIS / Inhibitor / MCL1 / MBP-fusion / BRD810 |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links






homo sapiens (human)
Keywords